SHANGHAI, July 21, 2025 /PRNewswire/ — CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, signaling robust growth in China’s thriving pharmaceutical sector.
Building on this success, CPHI & PMEC Shenzhen 2025 is slated for September 1-3, 2025, at the Shenzhen Convention & Exhibition Center (SZCEC). The event aims to meet the surging demand for access to South China’s key pharma markets.
Shenzhen, a crucial gateway to the Guangdong-Hong Kong-Macau Greater Bay Area, is poised to become a powerhouse of pharmaceutical innovation. Industry experts project the region’s health sector GDP to surpass 2 trillion CNY (approximately 1.5 billion USD) by 2028, potentially reaching 2.5 to 3 trillion CNY (1.88-2.25 billion USD) by 2030. This growth presents unprecedented opportunities for industry players.
CPHI & PMEC Shenzhen 2025 is set for remarkable expansion, doubling its exhibition space to 30,000 square meters. The event will showcase over 600 carefully selected exhibitors from diverse pharmaceutical sectors, including ingredients, excipients, biotech, contract services, machinery, and packaging. New additions include expanded zones for natural supply, finished dosage forms, clean technology, and laboratory instruments. A novel ‘Beauty & Cosmetics Supply Chain Zone’ will spotlight products and foster partnerships in this booming sector.
The exhibition will feature more than 20 high-level forums, bringing together regulatory authorities, academic experts, and industry leaders. These sessions will offer in-depth analysis of policy shifts, technological breakthroughs, and emerging market dynamics. Topics will range from new drug R&D and API process optimization to CXO collaborations, emerging market strategies, and innovations in nutrition, health foods, and medical aesthetics.
To facilitate strategic partnerships, organizers will host exclusive Buyer Matchmaking sessions and plant visits. These initiatives aim to spark meaningful connections between suppliers and international buyers with specific procurement needs.
With its strategic location and focused agenda, CPHI & PMEC Shenzhen 2025 is poised to redefine pharmaceutical innovation in South China. The event promises unparalleled networking, knowledge exchange, and collaborative opportunities, empowering attendees to tap into new growth avenues across Asia’s dynamic pharmaceutical landscape.
Register before August 1 to secure complimentary VIP benefits:
https://reg.cphi-china.cn/en/express-ticketing/shenzhenvip
For more information, visit:
https://www.cphi.com/china/en-gb/home.html
Most Commented